Navigation Links
Acorda Therapeutics Presentation of Fampridine-SR Phase 3 Data,Selected for Scientific Highlights Program at the American Academy,of Neurology Meeting

ics disclaims any intent or obligation to update any forward-looking statements as a result of developments occurring after the date of this press release.

About Acorda Therapeutics

Acorda Therapeutics is a biotechnology company developing therapies for SCI, MS and related nervous system disorders. The Company's marketed products include Zanaflex Capsules(TM) (tizanidine hydrochloride), a short-acting drug for the management of spasticity. For full prescribing information, please go to www.zanaflexcapsules.com. Acorda's lead clinical stage product, Fampridine-SR, recently completed a Phase 3 study in people with MS. The Company's pipeline includes a number of products in development for the treatment, regeneration and repair of the spinal cord and brain.

Contact

Acorda Therapeutics
Erica Wishner, 914-347-4300 ext. 162
ewishner@acorda.com


'"/>




Page: 1 2

Related medicine technology :

1. Acorda Therapeutics Presents Fampridine-SR Data at ACTRIMS Meeting
2. Acorda Therapeutics Presents Data from its Phase 3 Study of Fampridine-SR in Multiple Sclerosis at the American Academy of Neurology Meeting
3. Acorda Therapeutics to Host Analyst and Investor Reception
4. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
5. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
6. CV Therapeutics Identifies Potential Anti-Diabetic Mechanism of Action for Ranexa
7. Fat Kills Cancer: Turning Stem Cells from Fat Tissue into Personalized, Cancer-Targeted Therapeutics
8. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
9. Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical Study
10. Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin for Multiple Sclerosis
11. Orexigen Therapeutics to Present Data on Contrave Impact on Visceral Fat and Insulin Resistance at American Diabetes Association 67th Scientific Sessions in Chicago June 23
Post Your Comments:
(Date:10/12/2008)...tures thin struts designed for more uniform drug ...ass., and WASHINGTON, Oct. 12 /PRNewswire-FirstCal...today announced comprehensive data from,the TAXUS ...ctive,multi-center, single-arm, historically cont...(R) Paclitaxel-Eluting Stent System in a variety o...
(Date:10/10/2008)...phylaxis Treatment with Kogenate FS Reduces the,Ri... with No Pre-Existing,Joint Damage, BERKELEY, Cal...announced today that the U.S. Food and Drug Admini...th Kogenate(R) FS Antihemophilic Factor,(Recombina...nd the risk of,joint damage in patients aged 0-16 ...
(Date:10/9/2008)...gn to Spread Awareness and Bring Hope to Millions,...re-USNewswire/ -- 133 million children,across the ... as natural,disaster, civil war, and disease. SOS ...ld Orphan Week by calling attention to the needs o... Release, go to:, http://www.prnewswire.com/mnr/...
(Date:10/9/2008)... Science Institute, Navigenics, Affymetrix and,Mic...IEGO, Oct. 9 /- A consortium of healt...d forces in a first-of-its-kind,research study to ...esting,on people who choose to receive such screen...ng certain diseases., Sponsored by Scripps Transl...
Breaking Medicine Technology:Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientific's Next-Generation Taxus Liberte Stent 2Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientific's Next-Generation Taxus Liberte Stent 3Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientific's Next-Generation Taxus Liberte Stent 4Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientific's Next-Generation Taxus Liberte Stent 5Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientific's Next-Generation Taxus Liberte Stent 6FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 2FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 3FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 4FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 5Photos: SOS Children's Villages Observes World Orphan Week, October 5-11, 2008 2Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 2Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 3Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 4Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 5Worlds only captive hairy nosed otter gets new home 3679 1Worlds only captive hairy nosed otter gets new home 3679 2Worlds only captive hairy nosed otter gets new home 3679 3 24100 million supercomputing program boosts Australian medical research capacity 22167 1 24100 million supercomputing program boosts Australian medical research capacity 22167 2Non Surgical Approach Can Treat Lung Cancers 22162 1Non Surgical Approach Can Treat Lung Cancers 22162 2Nuvelo to Present at Jefferies 2nd Annual Healthcare Conference 22157 1
...tients With Improved Potential,to Battle Their Dis...-FirstCall/ --,Arrowhead Research Corporation anno...aries, Insert Therapeutics Inc. and Calando,Pharma...erican,Association for Cancer Research (AACR) Annu... research findings on two,anticancer therapies cur...
...6, 2007 - Introgen Therapeutics,Inc. (NASDAQ:INGN...the weekend in Los Angeles, California at the Annu...Research., Abnormality of the p53 tumor suppressor...ar defects in cancer. ADVEXIN,s,mechanism of actio...nction and the detection of abnormal p53 is a logi...
Other Medicine Technology:Arrowhead Subsidiaries Insert & Calando Present Data on,Cyclosert Drug Delivery System at AACR Meeting 2Arrowhead Subsidiaries Insert & Calando Present Data on,Cyclosert Drug Delivery System at AACR Meeting 3Arrowhead Subsidiaries Insert & Calando Present Data on,Cyclosert Drug Delivery System at AACR Meeting 4Introgen Presents ADVEXIN Biomarker Data at Major Cancer Conference 2Introgen Presents ADVEXIN Biomarker Data at Major Cancer Conference 3Introgen Presents ADVEXIN Biomarker Data at Major Cancer Conference 4
(Date:10/10/2008)...Coach Holly Warlick Teams Up with Legal and Medica...Ever Cancer and Careers Seminar in,Knoxville, KNO...ion of National,Breast Cancer Awareness Month, Can...e joined forces with YWCA Knoxville, The Wellness ...e Holly Warlick, University of Tennessee,women,s b...
(Date:10/10/2008)... The Healthcare Technology Ev... , Exton, PA (PRWEB) Sept...ey Chapters of the national Healthcare Information...forces to bring regional health information techno... conference entitled The Healthcare Technology Evo...
(Date:10/10/2008)...ston, MABoston Medical Center (BMC) has received a...l Institute on Aging (NIA) to fund the Boston Clau...BMC,s Pepper Center is one of only 11 Pepper Cente... Americans Independence Center Program was establi...enator from Florida. During his five decades of pu...
(Date:10/10/2008)...olecular CT adds metabolic information from PET to...gnostic imaging for maximized workflow ...ICH, Germany, Oct. 10 /PRNewswire/ -- Siemens Heal...duces molecular CT, a new concept in,integrated im...d is a,practical solution for today,s shrinking he...
Breaking Medicine News(10 mins):Health News:Local Experts Help Women Living and Working with Cancer Even the Score 2Health News:Local Experts Help Women Living and Working with Cancer Even the Score 3Health News:Local Experts Help Women Living and Working with Cancer Even the Score 4Health News:HIMSS New Jersey and Delaware Valley Chapters Sponsor Regional Conference 2Health News:Boston Medical Center receives $5.8m grant 2Health News:Siemens Shapes the Future of Integrated Diagnostic Imaging 2Health News:Siemens Shapes the Future of Integrated Diagnostic Imaging 3Health News:Siemens Shapes the Future of Integrated Diagnostic Imaging 4
...ous for being extra conscious in front of the came...g her pins looking far from perfect . The usually...h above and below her knee, making her legs look h...irl was photographed while going for a shoot in ha...
...has sacked her kids' nanny for not turning up on t...hat the babysitter lied to her about visiting her ... the Algarve. The model had to take care of her s...did not turn up, and was delayed for Radio One sho...
... that kids ability to describe past incidences dev...m of researchers led by Yael Orbach at the Nationa...and the University of Cambridge. As part of the s...yzed forensic interviews of 250, 4 to 10-year-old ...
...ss has finally realised the true persona of her ex...e house and getting rid of his belongings, the sup...Slug. According to pals, Moss chose the nickname ...e junkie rockers habit of leaving a trail of nasty...
Other Medicine News:
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
Medicine Products: